Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-09 Sale |
2025-04-11 7:37 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) |
View |
| 2025-04-09 Sale |
2025-04-11 7:24 pm |
Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) |
View |
| 2025-04-07 Purchase |
2025-04-08 09:30 am |
Compass Therapeutics Inc. | CMPX | Anderman Jonathan Gen Counsel & Corporate Sec |
20,000 | $1.54 | $30,800 | 21,000 (Direct) |
View |
| 2025-04-07 Purchase |
2025-04-08 09:25 am |
Compass Therapeutics Inc. | CMPX | Lerner Neil CHIEF ACCOUNTING OFFICER |
20,000 | $1.42 | $28,400 | 320,000 (Direct) |
View |
| 2023-03-10 Purchase |
2023-03-10 1:34 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
10,000 | $3.37 | $33,700 | 6,021,873 (Direct) |
View |
| 2023-02-27 Purchase |
2023-02-27 11:39 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $3.98 | $79,600 | 6,011,873 (Direct) |
View |
| 2023-02-15 Purchase |
2023-02-15 10:47 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $3.86 | $77,200 | 5,991,873 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 5:12 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Shin Barry CFO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:12 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:11 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:11 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Lerner Neil SVP, CAO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:10 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:10 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Ferneau Philip Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:09 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:09 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec |
280,000 | $0 | 280,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:08 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 5:05 pm |
N/A 2035-02-11 |
Compass Therapeutics Inc. | CMPX | Boylan James P Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-02-08 Tax Withholding |
2025-02-11 10:37 am |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO |
41,687 | $3.5 | 6,470,825 (Direct) |
View |
| 2025-01-09 Tax Withholding |
2025-01-13 08:30 am |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CEO |
58,054 | $1.86 | 6,512,512 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 2:02 pm |
N/A 2034-12-09 |
Compass Therapeutics Inc. | CMPX | Shin Barry CFO |
400,000 | $0 | 800,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 2:02 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Shin Barry CFO |
400,000 | $1.65 | 800,000 (Direct) |
View |
Ownership |
2024-12-10 2:00 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Lerner Neil VP Finance |
0 | $0 | 880,000 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 08:49 am |
N/A 2034-08-13 |
Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2024-08-09 4:07 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec |
0 | $0 | 426,000 (Direct) |
View |
| 2024-03-08 Option Award |
2024-03-11 10:12 am |
N/A 2034-03-07 |
Compass Therapeutics Inc. | CMPX | Boylan James P Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-14 12:03 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-14 12:03 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-14 12:02 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-14 12:01 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-14 12:00 pm |
N/A 2034-02-08 |
Compass Therapeutics Inc. | CMPX | Ferneau Philip Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-09 12:50 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered CHIEF EXECUTIVE OFFICER |
49,198 | $1.45 | 3,124,426 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-09 12:49 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. PRESIDENT |
44,782 | $1.45 | 6,570,566 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A 2034-01-08 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer |
1,753,125 | $0 | 4,926,749 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer |
1,753,125 | $1.93 | 4,926,749 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A 2034-01-08 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. President of R&D |
637,500 | $0 | 7,252,848 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-10 10:31 am |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. President of R&D |
637,500 | $1.93 | 7,252,848 (Direct) |
View |
| 2023-11-17 Tax Withholding |
2023-11-21 2:10 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
64,415 | $1.5 | 1,420,499 (Direct) |
View |
| 2023-11-17 Tax Withholding |
2023-11-21 2:08 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
44,025 | $1.5 | 5,977,848 (Direct) |
View |
| 2023-04-21 Option Award |
2023-04-24 4:32 pm |
N/A 2033-04-20 |
Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-02-08 Option Award |
2023-02-10 4:01 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | WURZER DAVID M Director |
50,000 | $0 | 50,000 (Direct) |
View |